DNA-mediated immunization with glycoprotein D of equine herpesvirus 1 (EHV-1) in a murine model of EHV-1 respiratory infection

By Ruitenberg K.M.   Walker C.   Wellington J.E.   Love D.N.   Whalley J.M.  

Vaccine, Vol. 17, Iss. 3, 1999-02 ,pp. : 237-244

Elsevier

Access to resources Recommend Favorite

Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice

By Olsen C.W.   McGregor M.W.   Dybdahl-Sissoko N.   Schram B.R.   Nelson K.M.   Lunn D.P.   Macklin M.D.   Swain W.F.   Hinshaw V.S.  

Vaccine, Vol. 15, Iss. 10, 1997-07 ,pp. : 1149-1156

Elsevier

Access to resources Recommend Favorite

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes

By Gilbert S.C.   Schneider J.   Hannan C.M.   Hu J.T.   Plebanski M.   Sinden R.   Hill A.V.S.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1039-1045

Elsevier

Access to resources Recommend Favorite

Protection against Schistosoma mansoni infection with a recombinant baculovirus-expressed subunit of calpain

By Hota-Mitchell S.   Siddiqui A.A.   Dekaban G.A.   Smith J.   Tognon C.   Podesta R.B.  

Vaccine, Vol. 15, Iss. 15, 1997-10 ,pp. : 1631-1640

Elsevier

Access to resources Recommend Favorite

Immunization of mice with recombinant gp41 in a systemic prime/mucosal boost protocol induces HIV-1-specific serum IgG and secretory IgA antibodies

By Mantis N.J.   Kozlowski  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3990-4001

Elsevier

Access to resources Recommend Favorite